Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > New Press Release - Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors

<< Previous

Bullboard Posts

Next >>

Comment by Mork102on Apr 03, 2024 10:09am

150 Views

Post# 35967465

RE:New Press Release - Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors

I wonder if any buyers of the recent PP would have purchased knowing this?
the 2023 PP was offered and after closing we discovered the road to FC was washed out and the government had no plans to rebuild it
no access to the barite!!
No hope for this stock now
im looking into SBFM on nasdaq - a company that has actual sales

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch